Towards a Better Understanding of Epidemiology, Survival and Treatment in Myeloproliferative Neoplasms: Results of the European Leukemianet Registry (ERNEST study)
Tiziano Barbui(University of Bergamo), Claire Harrison(Guy's and St Thomas' NHS Foundation Trust), Alessandra Di Lelio(Mario Negri Sud Foundation), Francisco Cervantes(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Andreas Reiter(Heidelberg University), Konstanze Doehener(University Hospital Ulm), Sara Sisti(Mario Negri Sud Foundation), Andreas Hochhaus(Jena University Hospital), Dietger Niederwieser(Leipzig University of Applied Sciences), Alessandro M. Vannucchi(Azienda Ospedaliero-Universitaria Careggi), Mario Cazzola(Roche (Switzerland)), Peter Johansson(Linköping University), Arianna Masciulli(Ospedale Papa Giovanni XXIII), Björn Andréasson(NU Hospital Group), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Marco Scarano(Mario Negri Sud Foundation), Steffen Koschmieder(RWTH Aachen University), Gianni Tognoni(Mario Negri Sud Foundation), Francesco Passamonti(University of Milan)
Cited by 6
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
|Leukemia|2022|3.8k